Natco Pharma has commenced commercial operations at Finished Dosage Formulations (FDF) facility in Visakhapatnam. The facility is a part of the Special Economic Zone (SEZ) and intended to cater primarily to the US & other international markets.
Vizag facility is a key part of Natco Pharma’s capacity expansion plans for its pipeline of products and diversification into different geographies. From capability perspective, this facility will focus mostly on oral solid dosages (tablets and capsules), including a cytotoxic block for products in the oncology segment. An application with the US Food and Drug Administration (USFDA) is already filed for site transfer of the first product & to trigger a regulatory audit.
Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.
